中国医院用药评价与分析2024,Vol.24Issue(5) :594-597.DOI:10.14009/j.issn.1672-2124.2024.05.018

冠心宁片治疗冠心病心绞痛的临床综合评价

Clinical Comprehensive Evaluation of Guanxinning Tablets in the Treatment of Coronary Angina Pectoris

郭媛媛 何婷 马丽娜 毛柳英 郑长辉 牛源菲 顾媛媛 曹俊岭
中国医院用药评价与分析2024,Vol.24Issue(5) :594-597.DOI:10.14009/j.issn.1672-2124.2024.05.018

冠心宁片治疗冠心病心绞痛的临床综合评价

Clinical Comprehensive Evaluation of Guanxinning Tablets in the Treatment of Coronary Angina Pectoris

郭媛媛 1何婷 2马丽娜 2毛柳英 2郑长辉 1牛源菲 1顾媛媛 2曹俊岭3
扫码查看

作者信息

  • 1. 北京中医药大学中药学院,北京 100029
  • 2. 北京中医药大学东方医院药学部,北京 100078
  • 3. 北京中医药大学东直门医院洛阳医院,河南 洛阳 471934
  • 折叠

摘要

目的:对冠心宁片进行临床综合价值评价,为临床合理用药以及基本用药管理提供参考依据.方法:基于当前的研究数据和资料,围绕有效性、安全性、经济性、传承与创新性、适宜性、可及性 6 个维度,对冠心宁片治疗冠心病心绞痛进行临床综合性评价.结果:冠心宁片治疗冠心病心绞痛,在有效性方面,可提高心绞痛疗效、心电图疗效;在安全性方面,不良反应轻微,预后良好;在经济性方面,具有一定的成本-效果优势;在创新性方面,获批 9 项中国专利;在适宜性方面,方便服用、携带和储存;在可及性方面,药品覆盖广,可负担性较好.结论:冠心宁片治疗冠心病心绞痛具有一定的临床价值,可为药品遴选、临床用药提供参考依据.

Abstract

OBJECTIVE:To evaluate the clinical comprehensive value of Guanxinning tablets,so as to provide reference for clinical rational drug use and basic drug management.METHODS:Based on the current research data and materials,the clinical comprehensive evaluation of Guanxinning tablets in the treatment of coronary angina pectoris was carried out around effectiveness,safety,economy,inheritance and innovation,suitability and accessibility.RESULTS:In terms of effectiveness,Guanxinning tablets can improve the efficacy of angina pectoris and electrocardiogram.In terms of safety,the adverse drug reactions were mild and the prognosis was good.In terms of economy,Guanxinning tablets had cost-effectiveness advantages.In terms of innovation,nine Chinese patents were approved.In terms of suitability,Guanxinning tablets were convenient to take,carry and store.In terms of accessibility,Guanxinning tablets were widely covered and affordable.CONCLUSIONS:Guanxinning tablets has clinical value in the treatment of coronary angina pectoris,and can provide reference for drug selection and clinical use.

关键词

冠心宁片/临床综合评价/有效性/安全性/经济性/传承与创新性/适宜性/可及性

Key words

Guanxinning tablets/Clinical comprehensive evaluation/Efficacy/Safety/Economy/Inheritance and innovation/Suitability/Accessibility

引用本文复制引用

基金项目

北京市中医管理局-中药临床应用评价项目(2022)()

出版年

2024
中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
参考文献量56
段落导航相关论文